Elaine K. Perry
Elaine K. Perry publishes mostly in Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology, on topics such as Cholinesterase and Neurodegenerative Diseases, Neuroscience and Neuropharmacology Research and Nicotinic Acetylcholine Receptors Study.
- World rank
- #67,241 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #5,699 of 367,258
- Works
- 238
- Citations
- 34k
- Citations per work
- 140.9
What does Elaine K. Perry research?
Elaine K. Perry's work is mostly in Medicine (30%), Neuroscience (20%), Biochemistry, Genetics and Molecular Biology (18%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences9038.0%
- Neuroscience4920.4%
- Biochemistry, Genetics and Molecular Biology4217.6%
- Everything else7732.3%
- Health Sciences7129.7%
- Medicine7129.7%
- 1Molecular Biology18% of their works
- 2Cellular and Molecular Neuroscience15% of their works
- 3Pharmacology12% of their works
- 4Physiology10% of their works
- 5Neurology7% of their works
- 6Cognitive Neuroscience6% of their works
Research topics
- Cholinesterase and Neurodegenerative Diseases
- Neuroscience and Neuropharmacology Research
- Nicotinic Acetylcholine Receptors Study
- Alzheimer's disease research and treatments
- Parkinson's Disease Mechanisms and Treatments
- Dementia and Cognitive Impairment Research
- Receptor Mechanisms and Signaling
- Memory and Neural Mechanisms
Which keywords describe Elaine K. Perry's research?
The keywords of their largest research topics: Alzheimer's Disease, Pharmacology, Neurodegeneration, Oxidative Stress, Crystal Structure, Acetylcholinesterase, Cholinesterase Inhibitors and Neurotransmission.
- Memory
- G-Protein-Coupled Receptors
- Dementia
- Parkinson's Disease
- Amyloid Hypothesis
- Neuronal Signaling
- Neurotransmission
- Acetylcholinesterase
- Oxidative Stress
- Pharmacology
- Alzheimer's Disease
- Neurodegeneration
- Crystal Structure
- Cholinesterase Inhibitors
- Synaptic Plasticity
- Nicotinic Acetylcholine Receptors
- Tau Pathology
- a-Synuclein
- Mild Cognitive Impairment
- Hippocampus
- Signal Transduction
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Alzheimer's Disease1613 topics
- Pharmacology992 topics
- Neurodegeneration852 topics
- Oxidative Stress852 topics
- Crystal Structure822 topics
- Acetylcholinesterase771 topic
- Cholinesterase Inhibitors771 topic
- Neurotransmission621 topic
- Synaptic Plasticity621 topic
- Neuronal Signaling601 topic
- Nicotinic Acetylcholine Receptors601 topic
- Amyloid Hypothesis561 topic
- Tau Pathology561 topic
- Parkinson's Disease291 topic
- a-Synuclein291 topic
- Dementia241 topic
- Mild Cognitive Impairment241 topic
- G-Protein-Coupled Receptors221 topic
- Hippocampus221 topic
- Memory221 topic
- Signal Transduction221 topic
Where does Elaine K. Perry work?
Elaine K. Perry's main affiliation in the publication record is North Tyneside General Hospital, United Kingdom.
How many publications and citations does Elaine K. Perry have?
OpenAlex counts 238 works and 33,543 citations for Elaine K. Perry, an h-index of 80, ranking #67,241 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Elaine K. Perry
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Elaine K. Perry. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.